Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/24/23 16:01 | 7/20/23 | GRNA | Health | BioPrd | Biological Products, (No Diag | Cormorant Asset Management, LP | MA | H | (See bel | S | 0 | 0.00 | 0 | -9,189 | -100 | 0 | I | ||||||||||||||
9/7/22 16:11 | 6/1/22 | GRNA | Health | BioPrd | Biological Products, (No Diag | Ortega-Valle Marta | MA | O | Chief Bu | M.d | 7 | 0.2300 | 0 | 30 | New | 30 | D | ||||||||||||||
8/15/22 18:48 | 8/11/22 | GRNA | Health | BioPrd | Biological Products, (No Diag | Morningside Venture Investments Ltd | O9 | T | P | 12,000 | 3.92 | 0 | 3,061 | 22 | 16,919 | D | |||||||||||||||
8/15/22 17:12 | 8/11/22 | GRNA | Health | BioPrd | Biological Products, (No Diag | Builders Vision, LLC | AR | T | P | 25,500 | 3.92 | 0 | 6,505 | 41 | 22,348 | I | |||||||||||||||
8/15/22 17:03 | 8/11/22 | GRNA | Health | BioPrd | Biological Products, (No Diag | Walker Matthew Allen | MA | DT | P | 25,250 | 3.92 | 0 | 6,441 | 41 | 22,284 | M | |||||||||||||||
3/17/22 17:11 | 2/2/22 | GRNA | Health | BioPrd | Biological Products, (No Diag | Morningside Venture Investments Ltd | O9 | T | P.ad | 0 | 0.00 | 0 | 1,000 | 8 | 13,858 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |